mRNA-4157,Pembrolizumab
merck,moderna
['melanoma', '$mrk', 'merck', 'moderna']
moderna and merck s cancer vaccine cuts risk of recurrence or death 44% in late-stage, high-risk melanoma after resection $mrk via 
Evidence-Based #Oncology. Bringing together perspectives of 20,000+ cancer care #providers, #payers, #policymakers, #patients, and researchers in #cancer care.